• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 984-998 of 1,667 results

1095 Exhibit: Ex 1095 Wayback Affidavit 601

Document IPR2022-01226, No. 1095 Exhibit - Ex 1095 Wayback Affidavit 601 (P.T.A.B. Jul. 1, 2022)

cite Cite Document
Analyze

2267 Exhibit: Ex 2267 Visudyne Drug Label Apr 2016

Document IPR2022-01226, No. 2267 Exhibit - Ex 2267 Visudyne Drug Label Apr 2016 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2116 Exhibit: Ex 2116 NCT00943072

Document IPR2022-01226, No. 2116-2 Exhibit - Ex 2116 NCT00943072 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

1100 Exhibit: Ex 1100 Lesko Decl

Document IPR2022-01226, No. 1100 Exhibit - Ex 1100 Lesko Decl (P.T.A.B. Oct. 24, 2022)

cite Cite Document
Analyze

1076 Exhibit: Ex 1076 Zarbin

Document IPR2022-01226, No. 1076 Exhibit - Ex 1076 Zarbin (P.T.A.B. Jul. 1, 2022)

cite Cite Document
Analyze

1046 Exhibit: Ex 1046 Ferrara 2005

Document IPR2022-01226, No. 1046 Exhibit - Ex 1046 Ferrara 2005 (P.T.A.B. Jul. 1, 2022)

cite Cite Document
Analyze

2230 Exhibit: Ex 2230 Novartis Annual Report, 2020

Document IPR2022-01226, No. 2230 Exhibit - Ex 2230 Novartis Annual Report, 2020 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2162 Exhibit: Ex 2162 Beovu Drug Label June 2020

Document IPR2022-01226, No. 2162 Exhibit - Ex 2162 Beovu Drug Label June 2020 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

1132 Exhibit: Ex 1132 226 patent

Document IPR2022-01226, No. 1132 Exhibit - Ex 1132 226 patent (P.T.A.B. Jun. 29, 2023)

cite Cite Document
Analyze

1161 Exhibit: Ex 1161 Optometry Pharma

Document IPR2022-01226, No. 1161 Exhibit - Ex 1161 Optometry Pharma (P.T.A.B. Jun. 29, 2023)

cite Cite Document
Analyze

2162 Exhibit: Ex 2162 Beovu Drug Label June 2020

Document IPR2022-01226, No. 2162-2 Exhibit - Ex 2162 Beovu Drug Label June 2020 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2331 Exhibit: Ex 2331 338 FH Part 1 of 2

Document IPR2022-01226, No. 2331 Exhibit - Ex 2331 338 FH Part 1 of 2 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2178 Exhibit: Ex 2178 Donohue 2004

Document IPR2022-01226, No. 2178-2 Exhibit - Ex 2178 Donohue 2004 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2034 Exhibit: Ex 2034 FiercePharma 2021

Document IPR2022-01226, No. 2034-2 Exhibit - Ex 2034 FiercePharma 2021 (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze

2304 Exhibit: Ex 2304 FDA 22 Case Studies

Document IPR2022-01226, No. 2304 Exhibit - Ex 2304 FDA 22 Case Studies (P.T.A.B. Apr. 5, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 66 67 68 69 70 ... >>